Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
12.98
-0.26 (-1.96%)
May 14, 2025, 10:30 AM - Market open
Sotera Health Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1,107 | 1,100 | 1,049 | 1,004 | 931.48 | 818.16 | Upgrade
|
| Revenue Growth (YoY) | 2.78% | 4.88% | 4.54% | 7.75% | 13.85% | 5.12% | Upgrade
|
| Cost of Revenue | 496.18 | 498.15 | 472.13 | 446.68 | 412.81 | 374.59 | Upgrade
|
| Gross Profit | 610.61 | 602.3 | 577.16 | 557 | 518.67 | 443.57 | Upgrade
|
| Selling, General & Admin | 203.44 | 204.75 | 186.37 | 166.18 | 149.36 | 136.6 | Upgrade
|
| Operating Expenses | 265.07 | 266.79 | 250.16 | 229.12 | 213.14 | 195.63 | Upgrade
|
| Operating Income | 345.54 | 335.51 | 326.99 | 327.89 | 305.53 | 247.94 | Upgrade
|
| Interest Expense | -163.8 | -164.69 | -142.88 | -80.14 | -74.19 | -215.26 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.06 | -0.2 | -0.16 | -0.15 | -1.35 | 5.23 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.14 | 0.12 | 2.38 | -0.46 | 3.56 | 4.16 | Upgrade
|
| EBT Excluding Unusual Items | 181.83 | 170.74 | 186.34 | 247.14 | 233.55 | 42.07 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -9.61 | - | - | Upgrade
|
| Legal Settlements | -69.63 | -32.69 | -80.31 | -480.64 | -45.66 | -36.67 | Upgrade
|
| Other Unusual Items | -24.17 | -24.17 | - | - | -15.58 | -44.26 | Upgrade
|
| Pretax Income | 88.04 | 113.87 | 106.03 | -243.11 | 175.72 | -38.86 | Upgrade
|
| Income Tax Expense | 63.22 | 69.48 | 54.65 | -9.54 | 58.6 | -1.37 | Upgrade
|
| Earnings From Continuing Operations | 24.82 | 44.4 | 51.38 | -233.57 | 117.12 | -37.49 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | -0.24 | -1.13 | Upgrade
|
| Net Income | 24.82 | 44.4 | 51.38 | -233.57 | 116.88 | -38.62 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.04 | 0.06 | 0.29 | - | 1.52 | - | Upgrade
|
| Net Income to Common | 24.78 | 44.34 | 51.09 | -233.57 | 115.36 | -38.62 | Upgrade
|
| Net Income Growth | -54.76% | -13.58% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 283 | 283 | 281 | 280 | 279 | 238 | Upgrade
|
| Shares Outstanding (Diluted) | 285 | 285 | 283 | 280 | 279 | 238 | Upgrade
|
| Shares Change (YoY) | 0.45% | 0.60% | 1.12% | 0.26% | 17.54% | 2.28% | Upgrade
|
| EPS (Basic) | 0.09 | 0.16 | 0.18 | -0.83 | 0.41 | -0.16 | Upgrade
|
| EPS (Diluted) | 0.09 | 0.16 | 0.18 | -0.83 | 0.41 | -0.16 | Upgrade
|
| EPS Growth | -53.92% | -12.89% | - | - | - | - | Upgrade
|
| Free Cash Flow | 105.89 | 45.09 | -362.71 | 95.58 | 179.38 | 67.08 | Upgrade
|
| Free Cash Flow Per Share | 0.37 | 0.16 | -1.28 | 0.34 | 0.64 | 0.28 | Upgrade
|
| Gross Margin | 55.17% | 54.73% | 55.01% | 55.50% | 55.68% | 54.22% | Upgrade
|
| Operating Margin | 31.22% | 30.49% | 31.16% | 32.67% | 32.80% | 30.30% | Upgrade
|
| Profit Margin | 2.24% | 4.03% | 4.87% | -23.27% | 12.38% | -4.72% | Upgrade
|
| Free Cash Flow Margin | 9.57% | 4.10% | -34.57% | 9.52% | 19.26% | 8.20% | Upgrade
|
| EBITDA | 512.12 | 501.78 | 487.33 | 475.63 | 458.68 | 393.5 | Upgrade
|
| EBITDA Margin | 46.27% | 45.60% | 46.44% | 47.39% | 49.24% | 48.10% | Upgrade
|
| D&A For EBITDA | 166.58 | 166.28 | 160.34 | 147.75 | 153.15 | 145.56 | Upgrade
|
| EBIT | 345.54 | 335.51 | 326.99 | 327.89 | 305.53 | 247.94 | Upgrade
|
| EBIT Margin | 31.22% | 30.49% | 31.16% | 32.67% | 32.80% | 30.30% | Upgrade
|
| Effective Tax Rate | 71.81% | 61.01% | 51.54% | - | 33.35% | - | Upgrade
|
| Revenue as Reported | 1,107 | 1,100 | 1,049 | 1,004 | 931.48 | 818.16 | Upgrade
|
Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.